4//SEC Filing
MURRAY RICHARD /CA/ 4
Accession 0001640455-23-000053
CIK 0001640455other
Filed
Apr 5, 8:00 PM ET
Accepted
Apr 6, 4:37 PM ET
Size
5.1 KB
Accession
0001640455-23-000053
Insider Transaction Report
Form 4
MURRAY RICHARD /CA/
DirectorCEO and President
Transactions
- Sale
Common Stock
2023-04-04$1.85/sh−39,228$72,572→ 188,779 total
Footnotes (1)
- [F1]Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. The automatic sale instructions for the sell-to-cover were intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Securities Exchange Act of 1934, as amended, and to be interpreted to comply with the requirements of Rule 10b5-1(c), and these instructions were given on September 17, 2019.
Documents
Issuer
Jounce Therapeutics, Inc.
CIK 0001640455
Entity typeother
Related Parties
1- filerCIK 0001242935
Filing Metadata
- Form type
- 4
- Filed
- Apr 5, 8:00 PM ET
- Accepted
- Apr 6, 4:37 PM ET
- Size
- 5.1 KB